Full-Time

Field Reimbursement Manager

Confirmed live in the last 24 hours

Coherus BioSciences

Coherus BioSciences

201-500 employees

Develops and commercializes biosimilars for healthcare

Biotechnology
Healthcare

Compensation Overview

$165k - $190kAnnually

Senior

Remote in USA

Field-based role requires candidates to be located in the United States.

Category
Insurance
Finance & Banking
Required Skills
Inventory Management
Requirements
  • 5+ years of commercial experience in the pharmaceutical or biotech industry.
  • 3+ years of experience in healthcare coverage, coding and/or reimbursement.
  • Direct experience with Buy and Bill products, Medicare Part B and Miscellaneous J-Codes required.
  • Oncology experience strongly preferred.
  • Bachelor's degree from a four-year college or university.
  • Ability to analyze, interpret and understand regulatory and legislative payer and healthcare policies.
Responsibilities
  • Partner with internal and external stakeholders to identify, anticipate and address patient and practice reimbursement issues
  • Collaborate with Field Sales to identify facilities and practices that need reimbursement education and support regarding Coherus products.
  • Provide insights and updates regarding product and support service integration at accounts.
  • Educate facility staff on policies related to product acquisition, inventory management, and all payer polices related to support full integration of product into the practice workflow.
  • Provide coverage, coding, and reimbursement information to key staff members (i.e., practice administrators, reimbursement staff, and providers) in order to appropriately support patient access.
  • Collaborate with field facing 'One Team' to compliantly share insights into customer needs, potential barriers, and payer issues/opportunities for access at practices.
  • Communicate and explain payer policy updates or system changes that impact access.
  • Proactively communicate Coherus COMPLETE™ so that office staff is fluent in how to use patient access programs and services.
  • Address questions associated with patient coverage, access, and reimbursement from accounts in collaboration and coordination with patient services as directed by policy and procedure.
  • Conduct frequent claim reviews with practices to ensure appropriate reimbursement of Coherus products.
  • Maintain a deep understanding of Coherus policies and requirements and perform the role in a compliant manner consistent with company guidance.
  • Keep abreast of customer and market access industry trends.

Coherus BioSciences develops and sells biosimilars, which are highly similar versions of approved biologic medicines used to treat various diseases. These biosimilars are designed to be as effective and safe as the original products but are offered at a lower cost, making them more affordable for patients and healthcare systems. The company focuses on research, development, and commercialization of these products, ensuring they meet strict regulatory standards for quality and efficacy. Coherus aims to improve patient lives by expanding access to essential biologic treatments, helping to reduce healthcare costs. Their business model allows them to generate revenue through the sale of these cost-effective alternatives, giving them a competitive advantage in the biopharmaceutical market.

Company Stage

IPO

Total Funding

$114.5M

Headquarters

Redwood City, California

Founded

2010

Growth & Insights
Headcount

6 month growth

-8%

1 year growth

-13%

2 year growth

-20%
Simplify Jobs

Simplify's Take

What believers are saying

  • Collaboration with Cancer Research Institute enhances Coherus' position in cancer treatment innovation.
  • Udenyca wearable injector launch could capture significant pegfilgrastim market share.
  • Revised loan terms with Pharmakon Advisors improve financial flexibility for strategic growth.

What critics are saying

  • Sandoz's acquisition of biosimilar assets may erode Coherus' market share.
  • 30% staff reduction could hinder operational capabilities and product development.
  • Divestment of Canadian rights to Toripalimab may limit market presence in Canada.

What makes Coherus BioSciences unique

  • Coherus focuses on biosimilars, offering cost-effective alternatives to original biologics.
  • The company emphasizes oncology and inflammatory diseases, targeting high-demand therapeutic areas.
  • Coherus' Udenyca wearable injector device is a novel delivery system for pegfilgrastim.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Competitive base salary

Target bonus based on performance

stock options

Medical, dental, & vision coverage

PTO

401(k) plan

FSA